GLAXOSMITHKLINE LLC

Lobbying client · District of Columbia · filed 2025 to 2026

Pharmaceutical Company.

$270,000 Reported spend

6 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (59581), not by name.

Firms hired 1

LMH STRATEGIC SOLUTIONS $270,000 6 filings

Bills named in these filings 2

S 705
Innovation in Pediatric Drugs Act of 2025

3 filings
S 864
HELP Copays Act

1 filing

Reported by year 2 years

2026 $100,000 2 filings
2025 $170,000 4 filings

Issues lobbied 2

Health Issues 6
Pharmacy 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

HOUSE OF REPRESENTATIVES 6
SENATE 6
Executive Office of the President (EOP) 2
Health & Human Services, Dept of (HHS) 2

Recent filings 6 total

Q2

LMH STRATEGIC SOLUTIONS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 5, 2026

View → Q1

LMH STRATEGIC SOLUTIONS

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000 income · posted Apr 17, 2026

View → Q4

LMH STRATEGIC SOLUTIONS

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $50,000 income · posted Jan 12, 2026

View → Q3

LMH STRATEGIC SOLUTIONS

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $40,000 income · posted Oct 20, 2025

View → Q2

LMH STRATEGIC SOLUTIONS

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $40,000 income · posted Jul 15, 2025

View → Q1

LMH STRATEGIC SOLUTIONS

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $40,000 income · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.